FBCM
CELU icon

Fort Baker Capital Management’s Celularity CELU Stock Holding History

Fort Baker Capital Management’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-7,411
Closed -$778K – 60
2020
Q3 		$778K Buy
+7,411
New +$767K 0.31% 34

Other funds holding CELU

BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Fort Baker Capital Management's CELU Position: Q4 2020 in Review

Fort Baker Capital Management sold out of Celularity (CELU) in Q4 2020, closing a stake of 7,411 shares — an estimated $778K sold.

Fort Baker Capital Management first reported a position in CELU in Q3 2020 and held it in 1 quarter. The position peaked at $778K in Q3 2020. 64 funds tracked by Wall St. Rank hold CELU as of Q4 2020.

  • Fort Baker Capital Management reported no remaining Celularity position as of Q4 2020 after selling out during the quarter.
  • Fort Baker Capital Management sold 7,411 Celularity shares in Q4 2020, an estimated $778K.
  • Fort Baker Capital Management first reported a position in Celularity in Q3 2020 and held it in 1 quarter.
  • Fort Baker Capital Management's Celularity position peaked at $778K in Q3 2020.
  • 64 funds tracked by Wall St. Rank held Celularity as of Q4 2020.

Based on Fort Baker Capital Management's 13F filing for Q4 2020, filed 19 Feb 2021.